Thomas John C Insider Trading
Get the latest insider transactions of Thomas John C. Thomas John C is Director in QLT INC/BC ($QLTI) and Director in NantKwest, Inc. ($NK) and in Medovex Corp. ($MDVX) and Director in Medovex Corp. ($MDVX) and in Virios Therapeutics, Inc. ($VIRI). Discover the current value of Thomas John C shares.
Address: C/O MIMEDX, INC. 1234 AIRPORT RD., STE. 105 DESTIN 32541FL
Thomas John C is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
NVLN | NOVELION THERAPEUTICS INC. | Director | 37,000 | 72,150.00 |
NK | ImmunityBio, Inc. | Director | 207,477 | 1,060,207.47 |
MDVX | H-CYTE, INC. | Director | 115,960 | 120,598.40 |
VIRI | Virios Therapeutics, Inc. | 0 |
Insider Trading Transactions of Thomas John C
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | VIRI | Virios Therapeutics, Inc. | Thomas John C | Option Exercise | 6.50 | 7,875 | 51,188 | 7,875 | |
Jun 23 2021 | VIRI | Virios Therapeutics, Inc. | Thomas John C | Option Exercise | 6.50 | 7,875 | 51,188 | 7,875 | |
Dec 11 2020 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 10.83 | 42,592 | 461,122 | 207,477 |
Aug 21 2020 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 9.19 | 20,000 | 183,800 | 250,069 |
Aug 13 2020 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 10.35 | 19,790 | 204,827 | 310,279 |
Aug 13 2020 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 10.55 | 210 | 2,216 | 310,069 |
Aug 13 2020 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 9.49 | 20,000 | 189,800 | 290,069 |
Aug 13 2020 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 9.34 | 20,000 | 186,800 | 270,069 |
Jun 11 2020 | NK | NantKwest, Inc. | Thomas John C | Director | Option Exercise | 6.21 | 100,000 | 621,000 | 100,000 |
Dec 16 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 2.48 | 10,000 | 24,800 | 350,069 |
Dec 16 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 2.98 | 10,000 | 29,800 | 340,069 |
Dec 16 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 3.14 | 10,000 | 31,400 | 330,069 |
Dec 12 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 1.99 | 10,000 | 19,918 | 360,069 |
Sep 09 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 1.25 | 2,964 | 3,705 | 391,105 |
Sep 09 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 1.24 | 7,080 | 8,779 | 384,025 |
Sep 09 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 1.24 | 13,956 | 17,305 | 370,069 |
Jun 07 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Buy | 0.00 | 92,592 | 0 | 394,069 |
Jun 07 2019 | NK | NantKwest, Inc. | Thomas John C | Director | Buy | 0.00 | 92,592 | 0 | 394,069 |
Aug 13 2018 | NVLN | NOVELION THERAPEUTICS INC ... | Thomas John C | Director | Option Exercise | 3.33 | 10,000 | 33,300 | 10,000 |
Jun 11 2018 | NK | NantKwest, Inc. | Thomas John C | Director | Buy | 0.00 | 27,322 | 0 | 301,477 |
Jan 03 2018 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 0.00 | 4,500 | 0 | 274,155 |
Dec 19 2017 | MDVX | Medovex Corp. | Thomas John C | Director | Sell | 0.70 | 6,000 | 4,200 | 115,960 |
Nov 01 2017 | MDVX | Medovex Corp. | Thomas John C | Director | Buy | 1.17 | 12,821 | 15,001 | 109,960 |
Jun 21 2017 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 7.43 | 10,000 | 74,300 | 308,655 |
Jun 21 2017 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 7.44 | 20,000 | 148,800 | 288,655 |
Jun 21 2017 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 7.54 | 10,000 | 75,400 | 278,655 |
Jun 13 2017 | NK | NantKwest, Inc. | Thomas John C | Director | Buy | 0.00 | 23,753 | 0 | 318,655 |
Jun 01 2017 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 0.00 | 12,500 | 0 | 294,902 |
Jan 17 2017 | MDVX | Medovex Corp. | Thomas John C | Buy | 1.38 | 21,739 | 30,000 | 97,139 | |
Dec 27 2016 | QLTI | NOVELION THERAPEUTICS INC ... | Thomas John C | Director | Option Exercise | 8.65 | 9,600 | 83,040 | 9,600 |
Nov 29 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 7.50 | 6,168 | 46,260 | 309,621 |
Nov 23 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 7.50 | 13,000 | 97,500 | 322,789 |
Nov 23 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 7.50 | 7,000 | 52,500 | 315,789 |
Jun 21 2016 | QLTI | QLT INC/BC | Thomas John C | Director | Option Exercise | 1.43 | 50,000 | 71,500 | 50,000 |
Jun 21 2016 | QLTI | QLT INC/BC | Thomas John C | Director | Option Exercise | 0.00 | 6,400 | 0 | 28,400 |
May 27 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Buy | 0.22 | 277,725 | 60,016 | 335,789 |
May 27 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Option Exercise | 0.22 | 277,725 | 60,016 | 0 |
Mar 08 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 0.00 | 15,736 | 0 | 76,839 |
Mar 08 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 0.00 | 2,775 | 0 | 74,064 |
Mar 08 2016 | NK | NantKwest, Inc. | Thomas John C | Director | Sell | 0.00 | 16,000 | 0 | 58,064 |
Jul 01 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Buy | 3.67 | 12,500 | 45,875 | 24,500 |
Jul 01 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Buy | 3.30 | 12,500 | 41,250 | 37,000 |
Jul 01 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Option Exercise | 3.67 | 12,500 | 45,875 | 0 |
Jul 01 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Option Exercise | 3.30 | 12,500 | 41,250 | 0 |
Jun 09 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Buy | 0.00 | 4,000 | 0 | 6,000 |
Jun 09 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Buy | 0.00 | 6,000 | 0 | 12,000 |
Jun 09 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Option Exercise | 0.00 | 4,000 | 0 | 0 |
Jun 09 2015 | QLTI | QLT INC/BC | Thomas John C | Director | Option Exercise | 0.00 | 6,000 | 0 | 0 |